Tech Company Financing Transactions
Clearside Biomedical Funding Round
Clearside Biomedical closed a $16 million Series B funding round on 9/2/2014. Investors included Georgia Research Alliance Venture Fund, Hatteras Venture Partners and Mountain Group Capital.
Transaction Overview
Company Name
Announced On
9/2/2014
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Series B
Investors
Proceeds Purpose
Clearside expects to use proceeds from this financing to fund continued development of Clearside's proprietary suprachoroidal space (SCS) drug administration and advance its CLS-1001 and CLS-1003 programs into Phase 2 trials by the end of 2014.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
900 North Point Pkwy. 200
Alpharetta, GA 30005
USA
Alpharetta, GA 30005
USA
Phone
Website
Email Address
Overview
Clearside BioMedical (Nasdaq: CLSD) is an ophthalmic company specializing in the research, development and commercialization of therapeutic products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
George Lasezkay
Chief Financial Officer
Charlie Deignan
VP - Bus. Development
Rick McElheny
VP - Product Management
Rafael Andino
Browse more venture capital transactions:
Prev: 9/2/2014: Thar Pharmaceuticals venture capital transaction
Next: 9/2/2014: BoomBoom Prints venture capital transaction
Share this article
News on VC Transactions
We record all VC transactions involving tech companies. All VC database entries reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs